Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Via Medical was a medical technology company that specialized in automated point-of-care diagnostic systems for the critical care market. The company's primary innovation was the Via V-750 Blood Gas and Chemistry Monitor, which provided continuous, bedside monitoring of essential blood parameters including pH, oxygen, carbon dioxide, and glucose. By automating the sampling process through a patient's existing arterial line, the system significantly reduced the need for manual blood draws and minimized iatrogenic blood loss, a critical factor in neonatal care. The technology aimed to improve clinical decision-making by providing real-time data to healthcare providers in intensive care units. In 2001, Via Medical was acquired by International Technidyne Corporation (ITC), a subsidiary of Thoratec Corporation, for approximately $15 million. The acquisition integrated Via's monitoring technology into ITC's portfolio of bedside testing and blood management products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Via Medical.